ADINA CATALOGUE
Shop the
complete catalogue.
Search by product name or browse by category. Price, availability and the most important distinction stay visible throughout.
Showing all 8 results
-
Experimental
Endoluten
£46.0020 mgBatch file pendingPineal/circadian branding with uncertain composition, distinct from sequence-defined Epithalon.
UnavailableAsk about availability -
Preclinical
Epithalon
£58.0010 mgBatch file pendingA proposed pineal-derived bioregulator with telomere-focused claims, not a mitochondrial-targeting peptide.
UnavailableAsk about availability -
Preclinical
FOXO4-DRI
£92.0010 mgBatch file pendingA targeted experimental senolytic mechanism, not a mitochondrial support or endocrine peptide.
UnavailableAsk about availability -
Preclinical
Humanin
£68.0010 mgBatch file pendingPrimarily cytoprotective/anti-apoptotic, whereas MOTS-c centres on metabolic stress signalling.
UnavailableAsk about availability -
Experimental
Livagen
£46.0020 mgBatch file pendingA liver-tissue bioregulator concept rather than a systemic metabolic receptor agonist.
UnavailableAsk about availability -
Clinical research
NAD+
Price range: £52.99 through £72.99500 mg | 1000 mgBatch file pendingNAD+ is a metabolic coenzyme rather than a peptide or receptor agonist, so it belongs to cellular-metabolism research…
AvailableAdd to basket This product has multiple variants. The options may be chosen on the product page -
Clinical research
SS-31 (Elamipretide)
£29.9910 mgBatch file pendingDirectly targets mitochondrial membrane cardiolipin, unlike MOTS-c’s signalling-peptide role.
UnavailableAsk about availability -
Experimental
Vesugen
£46.0020 mgBatch file pendingVascular-tissue focus distinguishes it from mitochondrial or general healthy-ageing peptides.
UnavailableAsk about availability